Market Plandai Biotechnology Inc (OTCMKTS:PLPL) has announced the expansion of the agreement with USN. As per the reports, USN will now look forward to using its network for promoting Phytofare – Plandai’s flagship green tea based product in Australian and New Zealand market.
As part of the extended agreement, USN will use Phytofare in the development of a new product range to be sold globally including New Zealand and Australian markets. The initial agreement between both the firms urged USN to use Phytofare in all the green tea products being sold in South Africa and Europe.
The management teams of both the companies are excited to execute this agreement and hope that it will help them cater different markets in the course of the time. According to Callum Baylis-Duffield, VP Sales & Marketing, Plandai, USN has used Phytofare in the best possible way to deliver quality products to its customers.
Phytofare supplies active ingredients to the blood stream, which improve the overall health of the user. With USN’s wide network in Australia, New Zealand, South Africa and Europe, Plandai is optimistic about the long-term success of this Agreement.
Metabolix, Inc. (NASDAQ:MBLX) has made the announcement regarding the launch of Yield10 Bioscience so that it can develop and commercialize world-class innovative solutions in crop science. The announcement was made by the company through a press release. The press release claims that Yield10’s complete focus is on the development of proprietary technologies for the overall improvement of yield in crops on the basis of its T3″ transcriptome targeted metabolic engineering platform.
Meanwhile Herborium Group, Inc. (OTCMKTS:HBRM) has launched a host of next generation websites focusing on the promotion of AcnEase – its flagship product on a global level. As per the reports, AcnEase is famous for offering natural treatments for rosacea and acne. These websites are desktop and mobile feasible.